{
    "nctId": "NCT00160901",
    "briefTitle": "Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer",
    "officialTitle": "Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Difference in the sum score of the most common side effects of a chemotherapy (fatigue, nausea, loss of appetite, constipation, diarrhea) measured by the EORTC QLQ C30 3-5 weeks after and before 3 cycles of chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Indication for chemotherapy for breast cancer for at least 3 cycles\n\nExclusion Criteria:\n\n* Prior chemotherapy within 12 months\n* use of herbal or nutritional supplements or other complementary or alternative medications \u2265 7 days prior to start of chemotherapy and during the trial\n* allergy to study medication\n* Selenium intoxication\n* Current use of cumarins or other medication influencing the coagulation system\n* Edema in case of impaired cardial or renal function\n* Other severe medical condition\n* Psychiatric or central neurological disorders\n* Regular fluid intake \\< 2000 ml per day",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}